CARDIAC INVOLVEMENT IN INTERSTITIAL LUNG DISEASES
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Clinicians managing patients with Interstitial Lung Diseases (ILD) commonly recognize that the lungs represent only part of the disease. Breathlessness disproportionate to lung function, early desaturation, or rising natriuretic peptides often signal cardiac stress before overt pulmonary decline is measurable. Subtle strain changes, atrial remodeling, or arrhythmias can appear months before lung parameters worsen, and these markers carry significant prognostic weight. In children, interstitial lung diseases are approximately ten times less common than in adults. Moreover, pediatric cases present with highly heterogeneous etiologies, and some subtypes may follow an extremely severe course. Due to this rarity, the available literature is largely based on adult patients. Risk assessment today is strengthened by multimodal imaging-strain echocardiography, cardiac MRI-combined with biomarkers. This chapter integrates recent evidence with bedside observations to outline mechanisms, recognition, diagnostics, prognosis, and management of cardiac involvement in ILD.Keywords: Interstitial lung disease; Cardiac involvement; Pulmonary hypertension; Right ventricular dysfunction; Speckle-tracking echocardiography
Fields of Study & Subjects
Pulmonary Hypertension Research and Treatments
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Cardiovascular Function and Risk Factors
Publication details
- Journal / source
- Turkiye Klinikleri eBooks
- Pages
- 415–420
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Book chapter